The Federal Commission for the Protection against Health Risks (Cofepris) reported this Wednesday that the pharmaceutical companies that requested the health register of vaccines contra COVID-19 require more time to provide information to obtain authorization for your Commercial use.
Through a statement, the regulatory authority pointed out that Pfizer SA de CVvaccine producer Comirnaty; y ModernaTx. Inc. (through your legal representative in Mexico, Asofarma SA de CV), vaccine producer Spikevax monovalenterequired more time to have elements and technical information that they were missing.
The commission reiterated its “interest in evaluating these health supplies as a priority,” so the group of dictators designated for this task remains waiting to receive the elements that the laboratories must provide.
Cofepris reiterated its transparency and determination to protect health and guarantee healthcare access with high quality standards.
With information from López-Dóriga Digital
2023-11-30 01:22:45
#Cofepris #postpones #authorization #marketing #vaccines #COVID19 #require #time
